Alteration in body image for the patient undergoing RIL-2/LAK cell therapy.
Becker
K
K
Duke University Medical Center, Oncology Research Unit, Durham, NC.
Koutlas
J
J
D001828:Body Image; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D015979:Killer Cells, Lymphokine-Activated; D009369:Neoplasms / Q000523:psychology* / Q000628:therapy; D009859:Oncology Nursing; D011994:Recombinant Proteins / Q000009:adverse effects
D007376:Interleukin-2; D011994:Recombinant Proteins